{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:09:45Z","timestamp":1759838985956},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T00:00:00Z","timestamp":1266451200000},"content-version":"vor","delay-in-days":2789,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2002,7]]},"abstract":"<jats:p>Nine cocaine abusers with cerebral blood flow (CBF) deficits (hypo\u2010perfused areas) on HMPAO SPECT scans were compared to six without these deficits after six doses of isradipine (5 mg TID). When comparing the scan before isradipine to that after using SPM analysis, the ratio of hypo\u2010 to hyper\u2010fusion showed a 16% increase in the maximum Z scores and 30% fewer areas of hypo\u2010perfusion among those cocaine abusers with deficits. These deficits may represent segmental cerebral vasospasm that was reversed by this vasodilating agent in cocaine abusers with areas of hypo\u2010perfusion (deficits) as baseline.<\/jats:p>","DOI":"10.1080\/10550490290087983","type":"journal-article","created":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T05:39:49Z","timestamp":1083389989000},"page":"200-208","source":"Crossref","is-referenced-by-count":14,"title":["Isradipine Enhancement of Cerebral Blood Flow in Abstinent Cocaine Abusers with and without Chronic Perfusion Deficits"],"prefix":"10.1111","volume":"11","author":[{"given":"P.C.H.","family":"Gottschalk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,18]]},"reference":[{"issue":"4","key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s002130050575","article-title":"Isradipine prevents global and regional cocaine\u2010induced changes in brain blood flow: a preliminary study","volume":"136","author":"Johnson B","year":"1998","journal-title":"Psychopharmacology"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.5.376"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)00158-0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.152.5.641"},{"key":"e_1_2_6_6_2","first-page":"960","article-title":"Regional brain metabolic activity during different stages of cocaine withdrawal","volume":"32","author":"Volkow ND","year":"1991","journal-title":"J Nucl Med"},{"issue":"55","key":"e_1_2_6_7_2","first-page":"723","article-title":"Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users","volume":"34","author":"Holman BL","year":"1993","journal-title":"J Nucl Med"},{"issue":"7","key":"e_1_2_6_8_2","first-page":"1211","article-title":"Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine","volume":"36","author":"Levin JM","year":"1995","journal-title":"J Nucl Med"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00228-5"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00038-6"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1996.84.3.0405"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/105504999306117","article-title":"Interactions of cocaine with nimodipine: a brief report","volume":"8","author":"Kosten TR","year":"1999","journal-title":"Am J Addict"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(98)00084-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(99)00129-X"},{"issue":"2","key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0091-3057(97)00593-5","article-title":"Isradipine combined with naltrexone persistently reduces the reward\u2010relevant effects of cocaine and alcohol","volume":"60","author":"Cramer CM","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"e_1_2_6_16_2","volume-title":"Structured Clinical Interview for DSM\u2010IV. Patient Edition","author":"First MB","year":"1995"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"issue":"7","key":"e_1_2_6_18_2","first-page":"663","article-title":"Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies [editorial]","volume":"25","author":"Acton PD","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-199801000-00027"},{"issue":"1","key":"e_1_2_6_20_2","first-page":"203","article-title":"Mean regional cerebral blood flow images of normal subjects using technetium\u201099m\u2010HMPAO by automated image registration","volume":"39","author":"Imran MB","year":"1998","journal-title":"J Nucl Med"},{"issue":"2","key":"e_1_2_6_21_2","first-page":"189","article-title":"Statistical parametric maps in functional imaging: a general linear approach","volume":"4","author":"Friston KJ","year":"1995","journal-title":"Hum Brain Map"},{"key":"e_1_2_6_22_2","unstructured":"GottschalkPC Kosten TR.Cerebral perfusion defects in combined cocaine and alcohol dependence. In press."},{"issue":"3","key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/nimg.1995.1024","article-title":"Tests for distributed, nonfocal brain activations","volume":"2","author":"Worsley KJ","year":"1995","journal-title":"Neuroimage"},{"issue":"2","key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1152\/jappl.1994.77.2.834","article-title":"Effects of cocaine, benzoylecgonine, and cocaine metabolites in cannulated pressurized fetal sheep cerebral arteries","volume":"77","author":"Schreiber MD","year":"1994","journal-title":"J Appl Physiol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00299-9"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00501-I"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F10550490290087983","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/10550490290087983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T08:23:36Z","timestamp":1705134216000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1080\/10550490290087983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["10.1080\/10550490290087983"],"URL":"https:\/\/doi.org\/10.1080\/10550490290087983","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}